Novo Nordisk A/S
NVO
$44.96
$0.571.28%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 20.52% | 5.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 20.52% | 5.03% | |||
| Cost of Revenue | -5.46% | -2.57% | |||
| Gross Profit | 26.19% | 6.85% | |||
| SG&A Expenses | -24.05% | 8.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 228.92% | -- | |||
| Total Operating Expenses | -16.52% | 4.70% | |||
| Operating Income | 66.66% | 5.45% | |||
| Income Before Tax | 79.17% | 33.30% | |||
| Income Tax Expenses | 83.89% | 31.69% | |||
| Earnings from Continuing Operations | 77.89% | 33.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 77.89% | 33.74% | |||
| EBIT | 66.66% | 5.45% | |||
| EBITDA | 69.67% | -0.05% | |||
| EPS Basic | 77.94% | 33.73% | |||
| Normalized Basic EPS | 62.85% | 6.67% | |||
| EPS Diluted | 77.85% | 33.62% | |||
| Normalized Diluted EPS | 62.85% | 6.61% | |||
| Average Basic Shares Outstanding | -0.02% | 0.00% | |||
| Average Diluted Shares Outstanding | -0.02% | 0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -1.00% | |||